Atrial Fibrillation and Circulation - Cardiovascular Update

Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular events

Medical Xpress - Cardiology

APRIL 15, 2024

An analysis of the biomolecule substudy of the EAST–AFNET 4 trial has revealed that biomolecule concentrations in the blood of patients with atrial fibrillation can be used to identify patients at high and low cardiovascular risk. The findings were published in Cardiovascular Research.

Atrial Fibrillation

Atrial Fibrillation Circulation Research

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure

Heart BMJ

JANUARY 29, 2025

Background We evaluated the potential of circulating bone morphogenetic protein 10 (BMP10) as a biomarker for atrial stress and remodelling in patients with heart failure (HF), in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP). We also assessed the predictive value of BMP10 for adverse clinical outcomes.

Heart Failure

Heart Failure Circulation Biomarkers Atrial Fibrillation

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

DAIC

MARCH 28, 2024

Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Epidemiology of Atrial Fibrillation in the 21st Century. Epidemiology of Atrial Fibrillation in the 21st Century. Circulation Research. Int J Stroke. 2021 Feb;16(2):217-221. doi: 10.1177/1747493019897870.

Atrial Fibrillation

Atrial Fibrillation AFIB Ablation Pulmonary

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation

DAIC

DECEMBER 14, 2023

About Atrial Fibrillation and Pulsed Field Ablation AF is one of the most common and undertreated heart rhythm disorders, affecting more than 60 million people worldwide3. Circulation. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. November 2023.

Atrial Fibrillation

Atrial Fibrillation Ablation Technology Heart Failure

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

DECEMBER 29, 2023

Circulation. Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF.

Atrial Fibrillation

Atrial Fibrillation Ablation Atrial Flutter Blood Clot

Atrial dilatation in Atrial fibrillation : A query with multiple twists!

Dr. S. Venkatesan MD

APRIL 28, 2024

When atrial fibrillation (AF) begins, it can start with a single focus, degenerating to multiple wavelets, and it spreads throughout the entire surface area of both atria. A fibrillatory wave that occurs at a rate of more than 600 beats per minute can cause fatigue in the long run, leading to atrial dilation.

Atrial Fibrillation

Atrial Fibrillation Bicuspid/Mitral Pulmonary Ablation

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Journal of the American Heart Association

JANUARY 9, 2024

The increasing prevalence of atrial fibrillation (AF) in adults with congenital heart disease raises significant questions regarding its management. Journal of the American Heart Association, Ahead of Print. Finally, any remaining gaps in knowledge and potential areas of future research are highlighted.

Congenital Heart Disease

Congenital Heart Disease Atrial Fibrillation Congenital Heart Disease

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation

NOVEMBER 29, 2023

Circulation, Ahead of Print. Recommendations from the “2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” and the “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” have been updated with new evidence to guide clinicians.

Atrial Fibrillation

Atrial Fibrillation Risk Factors Ablation Arrhythmia

Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

Background Covert atrial fibrillation (AF) is a predominant aetiology of embolic stroke of undetermined source (ESUS). Conclusion Our study showed that posterior circulation infarcts with brainstem/cerebellum involvement are associated with AF detection in ESUS patients undergoing ILR.

Atrial Fibrillation

Atrial Fibrillation Embolism Strokes Stroke

Heritability of Atrial Fibrillation Among Swedish Adoptees

Circulation: Genomic and Precision Medicine

MAY 2, 2024

Circulation: Genomic and Precision Medicine, Ahead of Print.

Atrial Fibrillation

Atrial Fibrillation Circulation

Patients With Advanced Heart Failure and Atrial Fibrillation Deserve an Attempt at Catheter Ablation as First-Line Therapy

Circulation

OCTOBER 13, 2024

Circulation, Volume 150, Issue 16 , Page 1220-1222, October 15, 2024.

Atrial Fibrillation

Atrial Fibrillation Heart Failure Ablation Circulation

Rate vs Rhythm Control in Atrial Fibrillation

All About Cardiovascular System and Disorders

OCTOBER 25, 2023

Rate vs Rhythm Control in Atrial Fibrillation Rate vs rhythm control as a management strategy in atrial fibrillation has been a long standing topic for debate. EAST-AFNET 4 trial had 2789 patients with early atrial fibrillation and cardiovascular conditions [8]. years of follow up per patient. N Engl J Med.

Atrial Fibrillation

Atrial Fibrillation Heart Failure Ablation Cardiac Arrest

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58?464 Patients With Atrial Fibrillation

Circulation

JANUARY 24, 2024

Circulation, Ahead of Print. All findings were qualitatively similar when analyzed across BW.CONCLUSIONS:The treatment effect of NOAC versus warfarin in atrial fibrillation is generally consistent for stroke/SEE across the spectrum of BMI and BW, whereas the reduction in major bleeding is attenuated at a higher BMI and BW.

Atrial Fibrillation

Atrial Fibrillation BMI Strokes Stroke

AFib Might Be Far More Common Than We Think

CardiacWire

SEPTEMBER 11, 2024

A JACC study suggests that atrial fibrillation is far more prevalent than many previously thought, estimating that nearly one in 20 American adults have been diagnosed with the disease. That’s far higher than previous estimates, including a pair of JAMA and Circulation studies that estimated nationwide AFib rates of 2.26M and 5.1M

AFIB

AFIB Atrial Fibrillation Arrhythmia Research

Circulating ketone bodies, genetic susceptibility, with left atrial structure, function and atrial fibrillation: A prospective study from UK Biobank

HeartRhythm

OCTOBER 18, 2024

Metabolic remodeling has been recently pointed to play an important role in the pathological process of atrial fibrillation (AF). Ketone bodies (KB) are important cardiac metabolic energy source.

Atrial Fibrillation

Atrial Fibrillation Circulation

Patients diagnosed with new-onset, persistent AFib are more likely to have certain risk factors

Medical Xpress - Cardiology

FEBRUARY 22, 2024

Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib).

AFIB

AFIB Risk Factors Atrial Fibrillation Electrophysiology

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

DAIC

FEBRUARY 2, 2024

Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation [abstract].

Ablation

Ablation Atrial Fibrillation AFIB Heart Rhythm

iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection

DAIC

MARCH 31, 2025

AF Often Asymptomatic: Even for atrial fibrillation (AF)the most commonly symptomatic arrhythmiaover half of all cases were asymptomatic. Its estimated that undiagnosed atrial fibrillation alone costs the U.S. $3 Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. 2016;11(8).

Arrhythmia

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure

Transcutaneous Pacing: Part 2

EMS 12-Lead

MAY 15, 2024

After 13 minutes of ALS resuscitation, pulses were palpated indicating a return of spontaneous circulation. Initial vitals show hypertension (175/85), Atrial Fibrillation with RVR as seen in Figure 1 , hypercapnia (99mmHg), and SPO2 of 100%. After 5 minutes post-ROSC, the atrial fibrillation converted to a sinus rhythm.

Atrial Fibrillation

Atrial Fibrillation Bradycardia Pacemaker Cardiac Arrest

The “420” Cannabis Celebration and Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology

APRIL 3, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation

Atrial Fibrillation Electrophysiology Arrhythmia Circulation

Spatially Conserved Spiral Wave Activity During Human Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 13, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Atrial fibrillation is the most common cardiac arrhythmia in the world and increases the risk for stroke and morbidity. This finding could have important ramifications for identifying clinically important forms of atrial fibrillation and in guiding treatment.

Atrial Fibrillation

Atrial Fibrillation Arrhythmia Electrophysiology Circulation

Associations between circulating proteins and cardiometabolic diseases: a systematic review and meta-analysis of observational and Mendelian randomisation studies

Heart BMJ

SEPTEMBER 25, 2024

We aimed to synthesise existing evidence on the observational and genetic associations between circulating proteins and CMD. Two investigators independently extracted study characteristics using a standard form and pooled data using random effects models.

Circulation

Circulation Biomarkers Heart Failure Atrial Fibrillation

Circulating erythroferrone has diagnostic utility for acute decompensated heart failure in patients presenting with acute or worsening dyspnea

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Objectives In dyspneic patients with atrial fibrillation (AF) or obesity, the diagnostic performance of NT-proBNP for acute heart failure is reduced. In patients with AF, the AUC decreased for ERFE in each cohort (NZ: 0.71, n = 105, SG: 0.61, n = 44) but increased in patients with obesity (NZ: 0.79, n = 150, SG: 0.87, n = 164).

Heart Failure

Heart Failure Circulation Obesity Atrial Fibrillation

Story of magnesium for torsade de pointes

HeartRhythm

MARCH 26, 2024

Torsade de pointes (TdP) was not a rare arrhythmia in Israel during the 1970s–1980s as many patients, mainly with atrial fibrillation (AF), were treated with QT-prolonging antiarrhythmic drugs. Our experience was published in 1981 in Circulation.1

Atrial Fibrillation

Atrial Fibrillation Article Arrhythmia Circulation

What Is the Mechanism of Atrial Fibrillation Initiation?

Circulation

DECEMBER 25, 2024

Circulation, Volume 151, Issue 1 , Page 120-122, January 7, 2025.

Atrial Fibrillation

Atrial Fibrillation Circulation

Potential Effects of Mild Atrial Secondary Mitral Regurgitation in Patients With Isolated Atrial Fibrillation

Circulation: Cardiovascular Imaging

FEBRUARY 28, 2024

Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:Patients with only moderate atrial secondary mitral regurgitation (asMR) frequently develop heart failure (HF). Mechanisms of HF with moderate asMR and the impact of mild asMR remain unclarified.

Atrial Fibrillation

Atrial Fibrillation Bicuspid/Mitral Pulmonary Cardiovascular Imaging

What is strange about this paroxysmal atrial fibrillation in an otherwise healthy patient? And what happened after giving ibutilide?

Dr. Smith's ECG Blog

MARCH 15, 2023

Her Apple Watch suddenly told her that she is in atrial fibrillation. Patients with healthy AV nodes who are not on AV nodal blockers and who are not hyperkalemic should have a rapid ventricular response if they have paroxysmal Atrial fibrillation. Exam was completely normal except for an irregular heart rate.

Atrial Fibrillation

Atrial Fibrillation AFIB Arrhythmia Exercise

Early Rhythm Control, Lifestyle Modification and More Tailored Stroke Risk Assessment Are Top Goals in Managing Atrial Fibrillation

DAIC

DECEMBER 8, 2023

Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib). Additional Resources: After Nov.

Atrial Fibrillation

Atrial Fibrillation AFIB Strokes Stroke

Abstract 4141066: Multimodal Data-Based Longitudinal Prognostic Model for Predicting Atrial Fibrillation Recurrence after Catheter Ablation in Patients with Patent Foramen Ovale and Paroxysmal Atrial Fibrillation

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4141066-A4141066, November 12, 2024. Background:Clinical studies on atrial fibrillation (AF) recurrence after catheter ablation in patients diagnosed with patent foramen ovale (PFO) and paroxysmal AF (PAF) are scarce.

Atrial Fibrillation

Atrial Fibrillation Ablation Risk Factors Diabetes

Atrial Fibrillation: Why Are We Hiding Reality?

Circulation

MARCH 24, 2024

Circulation, Volume 149, Issue 13 , Page 979-980, March 26, 2024.

Atrial Fibrillation

Atrial Fibrillation Circulation

Abstract 4139226: Anticoagulation For Patients On Hemodialysis And Atrial Fibrillation

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4139226-A4139226, November 12, 2024. Background:Anticoagulation is the standard treatment for the majority of patients with atrial fibrillation (AF) to reduce the risk of stroke. Such patients are at high risk for bleeding and stroke.

Atrial Fibrillation

Atrial Fibrillation Aortic valve Bicuspid/Mitral Aortic

Understanding Contemporary Atrial Fibrillation Trends in the United States: The Importance of Different Perspectives

Circulation: Cardiovascular Quality & Outcomes

APRIL 3, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Atrial Fibrillation

Atrial Fibrillation Circulation Outcomes

Oxidative Stress Causes Mitochondrial and Electrophysiologic Dysfunction to Promote Atrial Fibrillation in Pitx2+/−Mice

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 24, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:The strongest genetic risk factors for atrial fibrillation (AF) are DNA variants on chromosome 4q25 near the transcription factor genePITX2.

Atrial Fibrillation

Atrial Fibrillation Electrophysiology Risk Factors Arrhythmia

Abstract 4135095: Outcomes of Atrial Fibrillation Patients with Thrombocytopenia: Insights From a Nationwide Database

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4135095-A4135095, November 12, 2024. Background:While anticoagulation is crucial for atrial fibrillation (AF) patients to prevent ischemic events, those with thrombocytopenia have a potential increased risk of bleeding.

Atrial Fibrillation

Atrial Fibrillation Outcomes Inpatient Hospital

Reduction in Left Atrial Epicardial Adipose Tissue Following Catheter Ablation for Atrial Fibrillation

Circulation: Arrhythmia and Electrophysiology

MARCH 20, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print.

Atrial Fibrillation

Atrial Fibrillation Electrophysiology Ablation Arrhythmia

Pulsed Field Ablation Using Focal Contact Force–Sensing Catheters for Treatment of Atrial Fibrillation: 1-Year Outcomes of the ECLIPSE AF Study

Circulation: Arrhythmia and Electrophysiology

DECEMBER 19, 2024

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Pulsed field ablation (PFA) is a promising treatment for atrial fibrillation. paroxysmal, and 58.5% deep sedation) were treated.

Atrial Fibrillation

Atrial Fibrillation Ablation Arrhythmia Outcomes

A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network

Circulation

JANUARY 8, 2024

Circulation, Ahead of Print. BACKGROUND:The relationship between heart failure (HF) and atrial fibrillation (AF) is clear, with up to half of patients with HF progressing to AF. The pathophysiological basis of AF in the context of HF is presumed to result from atrial remodeling.

Atrial Fibrillation

Atrial Fibrillation Heart Failure Electrophysiology Arrhythmia

Comparing Phenotypes for Acute and Long-Term Response to Atrial Fibrillation Ablation Using Machine Learning

Circulation: Arrhythmia and Electrophysiology

FEBRUARY 10, 2025

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:It is difficult to identify patients with atrial fibrillation (AF) most likely to respond to ablation.

Atrial Fibrillation

Atrial Fibrillation Ablation Physiology Arrhythmia

Left Atrial Strain Predicts Subclinical Atrial Fibrillation Detected by Long-term Continuous Monitoring in Elderly High-Risk Individuals

Circulation: Cardiovascular Imaging

MARCH 5, 2024

Circulation: Cardiovascular Imaging, Ahead of Print. BACKGROUND:Left atrial (LA) speckle tracking provides detailed information on atrial function. Its utility for predicting subclinical atrial fibrillation (SCAF) is unclear. Echocardiography included LA reservoir, conduit, and contraction strain.

Atrial Fibrillation

Atrial Fibrillation Cardiovascular Imaging Strokes Stroke

Abstract TP150: Magnetic Resonance Imaging Predictors of Atrial Fibrillation in Cryptogenic Stroke Cases

Stroke Journal

FEBRUARY 1, 2024

Detection of one cause, paroxysmal atrial fibrillation (AF), is critical to ensuring optimal treatment with direct oral anticoagulant (DOAC). The primary outcome, presence of occult atrial fibrillation, was detected by ICM placement within 90 days and follow-up within 180 days from stroke.

Atrial Fibrillation

Atrial Fibrillation Strokes Stroke Biomarkers

Abstract 4139970: Low-Dose Apixaban Safety and Efficacy in Patients with Atrial Fibrillation Who Have Gastrointestinal Bleed; A Nationwide Cohort Study

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4139970-A4139970, November 12, 2024. Introduction:Anticoagulation (AC) is the mainstay of thromboprophylaxis for stroke prevention in atrial fibrillation (AF) and is recommended.

Atrial Fibrillation

Atrial Fibrillation Coronary Artery Disease AFIB Heart Failure

Abstract 4145826: Atrial Fibrillation Screening During Sinus Rhythm Periods by Interrelated Systems Dynamics Analysis

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145826-A4145826, November 12, 2024. specificity.Conclusion:In this retrospective analysis, classification of the dynamic system model singular values identified patients at high risk for atrial fibrillation from sinus rhythm period. 17.64), yielding 72.9% sensitivity with 76.2%

Atrial Fibrillation

Atrial Fibrillation Circulation Stroke Strokes

Abstract 4137488: Mild elevation of [K+]0 reduces atrial fibrillation burden and enhances the efficacy of flecainide to suppress the arrhythmia: an experimental study.

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4137488-A4137488, November 12, 2024. Background:It is desirable to improve rhythm control management of atrial fibrillation (AF). Extracellular potassium ([K+]0) may affect AF generation and anti-AF efficacy of the sodium channel blockers.Methods:AF burden (i.e.,

Atrial Fibrillation

Atrial Fibrillation Arrhythmia Circulation

Abstract TP252: Forward Head Posturing as a Significant Risk Factor for Posterior Circulation Infarcts

Stroke Journal

FEBRUARY 1, 2024

Objective:Forward head posturing (FHP) has been associated with chronic anatomic vertebral artery disturbances possibly leading to posterior circulation ischemia. The data supporting FHP as a true risk factor of posterior circulation stroke has not been well established. The average C2 tilt of cases was 22.9 degrees compared to 17.7

Risk Factors

Risk Factors Circulation Atrial Fibrillation Ischemia

Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular events

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure

Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

Webinars

Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

Atrial dilatation in Atrial fibrillation : A query with multiple twists!

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder

Heritability of Atrial Fibrillation Among Swedish Adoptees

Patients With Advanced Heart Failure and Atrial Fibrillation Deserve an Attempt at Catheter Ablation as First-Line Therapy

Rate vs Rhythm Control in Atrial Fibrillation

Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58?464 Patients With Atrial Fibrillation

AFib Might Be Far More Common Than We Think

Circulating ketone bodies, genetic susceptibility, with left atrial structure, function and atrial fibrillation: A prospective study from UK Biobank

Patients diagnosed with new-onset, persistent AFib are more likely to have certain risk factors

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

iRhythm Unveils New Data Demonstrating Benefits of Long-Term Continuous Monitoring for Arrhythmia Detection

Transcutaneous Pacing: Part 2

The “420” Cannabis Celebration and Atrial Fibrillation

Spatially Conserved Spiral Wave Activity During Human Atrial Fibrillation

Associations between circulating proteins and cardiometabolic diseases: a systematic review and meta-analysis of observational and Mendelian randomisation studies

Circulating erythroferrone has diagnostic utility for acute decompensated heart failure in patients presenting with acute or worsening dyspnea

Story of magnesium for torsade de pointes

What Is the Mechanism of Atrial Fibrillation Initiation?

Potential Effects of Mild Atrial Secondary Mitral Regurgitation in Patients With Isolated Atrial Fibrillation

What is strange about this paroxysmal atrial fibrillation in an otherwise healthy patient? And what happened after giving ibutilide?

Early Rhythm Control, Lifestyle Modification and More Tailored Stroke Risk Assessment Are Top Goals in Managing Atrial Fibrillation

Abstract 4141066: Multimodal Data-Based Longitudinal Prognostic Model for Predicting Atrial Fibrillation Recurrence after Catheter Ablation in Patients with Patent Foramen Ovale and Paroxysmal Atrial Fibrillation

Atrial Fibrillation: Why Are We Hiding Reality?

Abstract 4139226: Anticoagulation For Patients On Hemodialysis And Atrial Fibrillation

Understanding Contemporary Atrial Fibrillation Trends in the United States: The Importance of Different Perspectives

Oxidative Stress Causes Mitochondrial and Electrophysiologic Dysfunction to Promote Atrial Fibrillation in Pitx2+/−Mice

Abstract 4135095: Outcomes of Atrial Fibrillation Patients with Thrombocytopenia: Insights From a Nationwide Database

Reduction in Left Atrial Epicardial Adipose Tissue Following Catheter Ablation for Atrial Fibrillation

Pulsed Field Ablation Using Focal Contact Force–Sensing Catheters for Treatment of Atrial Fibrillation: 1-Year Outcomes of the ECLIPSE AF Study

A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network

Comparing Phenotypes for Acute and Long-Term Response to Atrial Fibrillation Ablation Using Machine Learning

Left Atrial Strain Predicts Subclinical Atrial Fibrillation Detected by Long-term Continuous Monitoring in Elderly High-Risk Individuals

Abstract TP150: Magnetic Resonance Imaging Predictors of Atrial Fibrillation in Cryptogenic Stroke Cases

Abstract 4139970: Low-Dose Apixaban Safety and Efficacy in Patients with Atrial Fibrillation Who Have Gastrointestinal Bleed; A Nationwide Cohort Study

Abstract 4145826: Atrial Fibrillation Screening During Sinus Rhythm Periods by Interrelated Systems Dynamics Analysis

Abstract 4137488: Mild elevation of [K+]0 reduces atrial fibrillation burden and enhances the efficacy of flecainide to suppress the arrhythmia: an experimental study.

Abstract TP252: Forward Head Posturing as a Significant Risk Factor for Posterior Circulation Infarcts

Stay Connected